JPS5731616A - Relaxing agent for muscle comprising benzofurancarboxylic acid amide - Google Patents
Relaxing agent for muscle comprising benzofurancarboxylic acid amideInfo
- Publication number
- JPS5731616A JPS5731616A JP10513880A JP10513880A JPS5731616A JP S5731616 A JPS5731616 A JP S5731616A JP 10513880 A JP10513880 A JP 10513880A JP 10513880 A JP10513880 A JP 10513880A JP S5731616 A JPS5731616 A JP S5731616A
- Authority
- JP
- Japan
- Prior art keywords
- actions
- formula
- muscle
- agent
- relaxing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10513880A JPS5731616A (en) | 1980-08-01 | 1980-08-01 | Relaxing agent for muscle comprising benzofurancarboxylic acid amide |
US06/284,377 US4353923A (en) | 1980-08-01 | 1981-07-17 | Pharmaceutical composition containing a benzofurancarboxamide derivative as the active ingredient |
DE8181105944T DE3163391D1 (en) | 1980-08-01 | 1981-07-28 | A pharmaceutical composition containing a benzofuran-carboxamide derivative as the active ingredient |
EP81105944A EP0045473B1 (en) | 1980-08-01 | 1981-07-28 | A pharmaceutical composition containing a benzofuran-carboxamide derivative as the active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10513880A JPS5731616A (en) | 1980-08-01 | 1980-08-01 | Relaxing agent for muscle comprising benzofurancarboxylic acid amide |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5731616A true JPS5731616A (en) | 1982-02-20 |
JPS642088B2 JPS642088B2 (ja) | 1989-01-13 |
Family
ID=14399382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10513880A Granted JPS5731616A (en) | 1980-08-01 | 1980-08-01 | Relaxing agent for muscle comprising benzofurancarboxylic acid amide |
Country Status (4)
Country | Link |
---|---|
US (1) | US4353923A (ja) |
EP (1) | EP0045473B1 (ja) |
JP (1) | JPS5731616A (ja) |
DE (1) | DE3163391D1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4933351A (en) * | 1983-10-31 | 1990-06-12 | Merck Frosst Canada, Inc. | Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis |
US4663347A (en) * | 1983-10-31 | 1987-05-05 | Merck Frosst Canada, Inc. | Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis |
US4822803A (en) * | 1983-10-31 | 1989-04-18 | Merck Frosst Canada, Inc. | Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis |
DE19753850A1 (de) | 1997-12-04 | 1999-06-10 | Roche Diagnostics Gmbh | Probennahmevorrichtung |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2652399A (en) * | 1950-10-24 | 1953-09-15 | Sterling Drug Inc | Tertiary-aminoalkyl derivatives of coumarilic acids and their preparation |
NL277744A (ja) * | 1961-05-19 | |||
GB1233268A (ja) * | 1968-07-01 | 1971-05-26 | ||
US3915687A (en) * | 1973-11-12 | 1975-10-28 | Consortium Elektrochem Ind | Herbicide |
-
1980
- 1980-08-01 JP JP10513880A patent/JPS5731616A/ja active Granted
-
1981
- 1981-07-17 US US06/284,377 patent/US4353923A/en not_active Expired - Fee Related
- 1981-07-28 DE DE8181105944T patent/DE3163391D1/de not_active Expired
- 1981-07-28 EP EP81105944A patent/EP0045473B1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS642088B2 (ja) | 1989-01-13 |
DE3163391D1 (en) | 1984-06-07 |
EP0045473A1 (en) | 1982-02-10 |
EP0045473B1 (en) | 1984-05-02 |
US4353923A (en) | 1982-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5671074A (en) | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative | |
GB1380129A (en) | Benzofuran derivatives and preparation thereof | |
JPS5721320A (en) | Blood sugar level depressing agent | |
EA199801028A1 (ru) | Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний | |
EA199900374A1 (ru) | Ингибитор вторичной катаракты | |
JPS5731616A (en) | Relaxing agent for muscle comprising benzofurancarboxylic acid amide | |
JPS56131518A (en) | Antiallergic agent | |
DK0581904T3 (da) | Fremgangsmåde til inhibering af fibrose | |
HU903092D0 (en) | Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds | |
MX9206930A (es) | Nuevos compuestos | |
JPS5675428A (en) | Hypoglycemic agent containing procainamide hydrochloride | |
JPS57114512A (en) | Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative | |
GB1500666A (en) | Substituted pyrimido-quinoline derivatives and pharmaceutical compositions containing them | |
JPS5740409A (en) | Remedy for disease caused by extraordinary propagation of collagen | |
JPS5782314A (en) | Carcinostatic agent | |
JPS5634625A (en) | Antitumorigenic agent | |
JPS57197218A (en) | Central nervous system depressant containing thiazoline- 5-carboxylic acid derivative | |
JPS57128625A (en) | Carcinostatic | |
IE43848L (en) | Pharmaceutical compositions | |
IE37288B1 (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
JPS57108016A (en) | Antithrombotic agent | |
JPS54105237A (en) | Analgesic agent containing nalorphine-6-glucuronide | |
JPS5495734A (en) | Antiphlogistic analgesic agent | |
JPS5742620A (en) | Novel antiulcer agent | |
JPS57114513A (en) | Drug against arterioscleriosis comprising (3-dimethylca- rbamoxyphenyl)trimethyl ammonium derivative |